Dietary resveratrol supplementation normalizes gene expression in the hippocampus of streptozotocin-induced diabetic C57Bl/6 mice

Journal of Nutritional Biochemistry

Volumn 25, Issue 3, 2014, Pages 313-318

  Thomas, Jency ^a,b   Garg, Manohar Lal ^a,b   Smith, Doug William ^a,b  

^a UNIVERSITY OF NEWCASTLE   (Australia)

^b UNIVERSITY OF NEWCASTLE   (Australia)

Author keywords

Diabetes; Hippocampus; Histone acetylation; Inflammation; Resveratrol; Synaptic plasticity

Indexed keywords

DIABETES; HIPPOCAMPUS; HISTONE ACETYLATION; INFLAMMATION; RESVERATROL; SYNAPTIC PLASTICITY;

ANIMALS; BLOOD GLUCOSE; BODY WEIGHT; DIET; GENE EXPRESSION; HIPPOCAMPUS; MALE; MICE; MICE, INBRED C57BL; STILBENES; STREPTOZOCIN;

EID: 84893753285     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2013.11.005     Document Type: Article

References (58)

1. Liu Y., et al. Luteolin attenuates diabetes-associated cognitive decline in rats. Brain Res Bull 2013, 94:23-29.
2. Valastro B., et al. Up-regulation of glutamate receptors is associated with LTP defects in the early stages of diabetes mellitus. Diabetologia 2002, 45(5):642-650.
3. Revsin Y., et al. Neuronal and astroglial alterations in the hippocampus of a mouse model for type 1 diabetes. Brain Res 2005, 1038(1):22-31.
4. Reagan L.P., Magarinos A.M., McEwen B.S. Neurological changes induced by stress in streptozotocin diabetic rats. Ann N Y Acad Sci 1999, 893:126-137.
5. Arvanitakis Z., et al. Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function. Arch Neurol 2004, 61(5):661-666.
6. de la Lastra C.A., Villegas I. Resveratrol as an antioxidant and pro-oxidant agent: mechanisms and clinical implications. Biochem Soc Trans 2007, 35(Pt 5):1156-1160.
7. Wu J.M., Hsieh T.C. Resveratrol: a cardioprotective substance. Ann N Y Acad Sci 2011, 1215:16-21.
8. Albani D., et al. Neuroprotective properties of resveratrol in different neurodegenerative disorders. Biofactors 2012, 36(5):370-376.
9. Mokni M., et al. Effect of resveratrol on antioxidant enzyme activities in the brain of healthy rat. Neurochem Res 2007, 32(6):981-987.
10. Liu G.S., et al. Resveratrol attenuates oxidative damage and ameliorates cognitive impairment in the brain of senescence-accelerated mice. Life Sci 2012, 91(17-18):872-877.
11. Kennedy D.O., et al. Effects of resveratrol on cerebral blood flow variables and cognitive performance in humans: a double-blind, placebo-controlled, crossover investigation. Am J Clin Nutr 2010, 91(6):1590-1597.
12. Kamper A.M., et al. Basal cerebral blood flow is dependent on the nitric oxide pathway in elderly but not in young healthy men. Exp Gerontol 2004, 39(8):1245-1248.
13. Orgogozo J.M., et al. Wine consumption and dementia in the elderly: a prospective community study in the Bordeaux area. Rev Neurol (Paris) 1997, 153(3):185-192.
14. Luchsinger J.A., et al. Alcohol intake and risk of dementia. J Am Geriatr Soc 2004, 52(4):540-546.
15. Wang J., et al. Moderate consumption of Cabernet Sauvignon attenuates Abeta neuropathology in a mouse model of Alzheimer's disease. Faseb J 2006, 20(13):2313-2320.
16. Li F., et al. Resveratrol, a neuroprotective supplement for Alzheimer's disease. Curr Pharm Des 2012, 18(1):27-33.
17. Jeon B.T., et al. Resveratrol attenuates obesity-associated peripheral and central inflammation and improves memory deficit in mice fed a high-fat diet. Diabetes 2012, 61(6):1444-1454.
18. Kim Y.A., et al. Resveratrol inhibits nitric oxide and prostaglandin E2 production by lipopolysaccharide-activated C6 microglia. J Med Food 2007, 10(2):218-224.
19. Mirnics K., Pevsner J. Progress in the use of microarray technology to study the neurobiology of disease. Nat Neurosci 2004, 7(5):434-439.
20. Dennis G., et al. DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol 2003, 4(5):P3.
21. Schmittgen T.D., Livak K.J. Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc 2008, 3(6):1101-1108.
22. Thomas J., Garg M.L., Smith D. Altered expression of histone and synaptic plasticity associated genes in the hippocampus of streptozotocin-induced diabetic mice. Metab Brain Dis 2013, (Accepted for publication).
23. Chung J.H., Manganiello V., Dyck J.R. Resveratrol as a calorie restriction mimetic: therapeutic implications. Trends Cell Biol 2012, 22(10):546-554.
24. Thomas J., Garg M.L., Smith D.W. Dietary supplementation with resveratrol and/or docosahexaenoic acid alters hippocampal gene expression in adult C57Bl/6 mice. J Nutr Biochem 2013, 24:1735-1740.
25. Berger S.L. The complex language of chromatin regulation during transcription. Nature 2007, 447(7143):407-412.
26. Lubin F.D., et al. Epigenetic mechanisms: critical contributors to long-term memory formation. Neuroscientist 2011, 17(6):616-632.
27. Kadiyala C.S., et al. Acetylation of retinal histones in diabetes increases inflammatory proteins: effects of minocycline and manipulation of histone acetyltransferase (HAT) and histone deacetylase (HDAC). J Biol Chem 2012, 287(31):25869-25880.
28. Miao F., et al. In vivo chromatin remodeling events leading to inflammatory gene transcription under diabetic conditions. J Biol Chem 2004, 279(17):18091-18097.
29. Perrone L., et al. Thioredoxin interacting protein (TXNIP) induces inflammation through chromatin modification in retinal capillary endothelial cells under diabetic conditions. J Cell Physiol 2009, 221(1):262-272.
30. Reagan L.P. Diabetes as a chronic metabolic stressor: causes, consequences and clinical complications. Exp Neurol 2012, 233(1):68-78.
31. Broide R.S., et al. Distribution of histone deacetylases 1-11 in the rat brain. J Mol Neurosci 2007, 31(1):47-58.
32. Kim M.S., et al. An essential role for histone deacetylase 4 in synaptic plasticity and memory formation. J Neurosci 2012, 32(32):10879-10886.
33. Darcy M.J., et al. Regional and subcellular distribution of HDAC4 in mouse brain. J Comp Neurol 2010, 518(5):722-740.
34. Marzluff W.F., Wagner E.J., Duronio R.J. Metabolism and regulation of canonical histone mRNAs: life without a poly(A) tail. Nat Rev Genet 2008, 9(11):843-854.
35. Moriya J., et al. Resveratrol improves hippocampal atrophy in chronic fatigue mice by enhancing neurogenesis and inhibiting apoptosis of granular cells. Biol Pharm Bull 2011, 34(3):354-359.
36. Harada N., et al. Resveratrol improves cognitive function in mice by increasing production of insulin-like growth factor-I in the hippocampus. J Nutr Biochem 2011, 22(12):1150-1159.
37. Ogle W.O., Speisman R.B., Ormerod B.K. Potential of treating age-related depression and cognitive decline with nutraceutical approaches: a mini-review. Gerontology 2013, 59(1):23-31.
38. Deng W., Aimone J.B., Gage F.H. New neurons and new memories: how does adult hippocampal neurogenesis affect learning and memory?. Nat Rev Neurosci 2010, 11(5):339-350.
39. Justicia C., Gabriel C., Planas A.M. Activation of the JAK/STAT pathway following transient focal cerebral ischemia: signaling through Jak1 and Stat3 in astrocytes. Glia 2000, 30(3):253-270.
40. Wang X., et al. JAK/STAT pathway plays a critical role in the proinflammatory gene expression and apoptosis of RAW264.7 cells induced by trichothecenes as DON and T-2 toxin. Toxicol Sci 2012, 127(2):412-424.
41. Nicolas C.S., et al. The Jak/STAT pathway is involved in synaptic plasticity. Neuron 2011, 73(2):374-390.
42. Rico-Bautista E., Flores-Morales A., Fernandez-Perez L. Suppressor of cytokine signaling (SOCS) 2, a protein with multiple functions. Cytokine Growth Factor Rev 2006, 17(6):431-439.
43. Engelman J.A., Luo J., Cantley L.C. The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism. Nat Rev Genet 2006, 7(8):606-619.
44. Ceretta L.B., et al. Increased oxidative stress and imbalance in antioxidant enzymes in the brains of alloxan-induced diabetic rats. Exp Diabetes Res 2012, 2012:302682.
45. Giacco F., Brownlee M. Oxidative stress and diabetic complications. Circ Res 2010, 107(9):1058-1070.
46. Buttke T.M., Sandstrom P.A. Oxidative stress as a mediator of apoptosis. Immunol Today 1994, 15(1):7-10.
47. Orozco-Ibarra M., et al. Heme oxygenase-1 induction prevents neuronal damage triggered during mitochondrial inhibition: role of CO and bilirubin. Int J Biochem Cell Biol 2009, 41(6):1304-1314.
48. Saleem S., et al. Ginkgo biloba extract neuroprotective action is dependent on heme oxygenase 1 in ischemic reperfusion brain injury. Stroke 2008, 39(12):3389-3396.
49. Chen Y., et al. Upregulation of heme oxygenase-1 expression may facilitate memory and learning in mice. Exp Ther Med 2013, 5(5):1491-1495.
50. Cutajar M.C., Edwards T.M. Evidence for the role of endogenous carbon monoxide in memory processing. J Cogn Neurosci 2007, 19(4):557-562.
51. Chen C.Y., et al. Resveratrol upregulates heme oxygenase-1 expression via activation of NF-E2-related factor 2 in PC12 cells. Biochem Biophys Res Commun 2005, 331(4):993-1000.
52. Ates O., et al. Central nervous system protection by resveratrol in streptozotocin-induced diabetic rats. J Clin Neurosci 2007, 14(3):256-260.
53. Li Z.G., et al. Hippocampal neuronal apoptosis in type 1 diabetes. Brain Res 2002, 946(2):221-231.
54. Jafari Anarkooli I., et al. Evaluation of Bcl-2 family gene expression and Caspase-3 activity in hippocampus STZ-induced diabetic rats. Exp Diabetes Res 2008, 2008:638467.
55. Li Z.G., Zhang W., Sima A.A. C-peptide prevents hippocampal apoptosis in type 1 diabetes. Int J Exp Diabetes Res 2002, 3(4):241-245.
56. Ferguson S.C., et al. Apolipoprotein-e influences aspects of intellectual ability in type 1 diabetes. Diabetes 2003, 52(1):145-148.
57. Ellis R.J., et al. Cerebral amyloid angiopathy in the brains of patients with Alzheimer's disease: the CERAD experience. Part XV. Neurology 1996, 46(6):1592-1596.
58. Andrews-Zwilling Y., et al. Apolipoprotein E4 causes age- and Tau-dependent impairment of GABAergic interneurons, leading to learning and memory deficits in mice. J Neurosci 2010, 30(41):13707-13717.